US$ 20.26
retatrutide triple agonist glp-1 gip glucagon phase 2 obesity Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset Dual and Triple Gut Peptide
Description
GLP-1 and GIP control blood glucose levels by stimulating insulin secretion by pancreatic -cells while inhibiting glucagon secretion, increasing pancreatic -cell proliferation, and decreasing their apoptosis [3,4,5,6,7,8]

As glucose levels fall and your insulin needs drop, GLP-1 agonists stop stimulating the production of the hormone

SmartPill, a novel ambulatory diagnostic test for measuring gastric emptying in health and disease

Reduced appetite is the intended effect, though it sometimes feels too extreme
